© 2003 BMJ Publishing Group Ltd & Association of Clinical Pathologists
ECHO
Immunohistochemical expression patterns differ in recurrent and initial glioblastoma multiforme
| The first 150 words of the full text of this article appear below. |
There are significant differences in the expression patterns of the tumour suppressor gene p53, the cellular oncogene mdm2, epidermal growth factor receptor (EGFR) and the msh2 protein (part of the DNA mismatch repair system) in initial, as opposed to recurrent, glioblastoma multiforme. In particular, msh2 expressions may be affected by chemotherapy.
Twenty six adult patients were followed up whose tumour had been totally resected, 7 of whom were operated on for recurrence. Twenty three died at a mean of 532 days from diagnosis, while the mean progression free interval survival time was 204 days.
Recurrent lesions were characterised by reduced expression of p53 and msh2 while the numbers of mdm2, EGFR and msh2 positive specimens were reduced. The investigators suggest three possible reasons for reduced immunostaining: the antibody used in the study might not detect differentially expressed proteins; the expression level might actually decrease; or recurrent glioblastoma multiforme might represent
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
